NYSE:BCR - C R Bard Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding C R Bard Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $331.24 +331.24 (+∞) (As of 12/29/2017) Add Today's Range$331.24Now: $331.24▼$331.2450-Day Range N/A52-Week Range$222.42Now: $331.24▼$337.73VolumeN/AAverage Volume679,456 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email C. R. Bard, Inc (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry N/A Sub-IndustryHealth Care Equipment SectorN/A Current SymbolNYSE:BCR Previous Symbol CUSIP06738310 CIK9892 Webhttp://www.crbard.com/ Phone+1-908-2778000Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive BCR News and Ratings via Email Sign-up to receive the latest news and ratings for BCR and its competitors with MarketBeat's FREE daily newsletter. C R Bard (NYSE:BCR) Frequently Asked Questions What is C R Bard's stock symbol? C R Bard trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCR." How were C R Bard's earnings last quarter? C R Bard Inc (NYSE:BCR) issued its quarterly earnings data on Wednesday, October, 25th. The medical instruments supplier reported $3.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.96 by $0.06. The medical instruments supplier earned $989.80 million during the quarter, compared to analysts' expectations of $990.64 million. The firm's quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $2.64 earnings per share. View C R Bard's Earnings History. Has C R Bard been receiving favorable news coverage? News headlines about BCR stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. C R Bard earned a news sentiment score of 1.1 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for C R Bard. Who are some of C R Bard's key competitors? Some companies that are related to C R Bard include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Varian Medical Systems (VAR). What other stocks do shareholders of C R Bard own? Based on aggregate information from My MarketBeat watchlists, some companies that other C R Bard investors own include Abbott Laboratories (ABT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Johnson & Johnson (jnj), Medtronic (MDT), AbbVie (ABBV), Baxter International (BAX), Boston Scientific (BSX), AFLAC (AFL) and Bristol-Myers Squibb (BMY). Who are C R Bard's key executives? C R Bard's management team includes the folowing people: Timothy M. Ring, Chairman of the Board, Chief Executive Officer (Age 59)John H. Weiland, President, Vice Chairman of the Board, Chief Operating Officer (Age 61)James C. Beasley, Group President (Age 53)Timothy P. Collins, Group President (Age 56)John P. Groetelaars, Group President (Age 50)Christopher S. Holland, Chief Financial Officer, Senior Vice President (Age 50)Samrat S. Khichi, Senior Vice President, General Counsel, Secretary (Age 49)John A. DeFord Ph.D., Senior Vice President - Science, Technology and Clinical Affairs (Age 55)Frank Lupisella Jr., Vice President, Controller (Age 56)Betty D. Larson, Vice President - Human Resources (Age 41) What is C R Bard's stock price today? One share of BCR stock can currently be purchased for approximately $331.24. What is C R Bard's official website? The official website for C R Bard is http://www.crbard.com/. How can I contact C R Bard? C R Bard's mailing address is 730 Central Ave, NEW PROVIDENCE, NJ 07974-1139, United States. The medical instruments supplier can be reached via phone at +1-908-2778000. MarketBeat Community Rating for C R Bard (NYSE BCR)Community Ranking: 1.9 out of 5 ()Outperform Votes: 377 (Vote Outperform)Underperform Votes: 611 (Vote Underperform)Total Votes: 988MarketBeat's community ratings are surveys of what our community members think about C R Bard and other stocks. Vote "Outperform" if you believe BCR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BCR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2020 by MarketBeat.com StaffFeatured Article: What is diluted earnings per share (Diluted EPS)?